News & Insights


Talk im Turm – Parallel Import: ECJ Reboxing vs. Relabeling Decision

King & Spalding invites you to join a discussion on recent developments concerning parallel imports.

Parallel imports of pharmaceuticals and medical devices make up market shares of up to 40% in Germany. This leads to increased awareness among brand owners and original manufacturers. With the Falsified Medicines Directive, parallel traders saw a great opportunity to henceforth use their own packages at low cost ("reboxing"), which may lead to significant changes in the product. The ECJ has ruled in principle with 3 decisions dated 17.11.2022.

We look forward to discussing with you the opportunities that these ECJ rulings present for original manufacturers.


Please contact if you have any questions.

Event Details

Date: May 10, 2023

Time: 9:30 am (CEST)